ArticleVaccines2026

Evolution of National Influenza Vaccine Platform: From Comprehensive Preclinical Safety Validation of Trivalent Influenza Vaccine to Streamlined Immunogenicity of Quadrivalent Formulation.

Luka Dragačević et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.